Join
Live feed
·
SECFilingvia Quantisnow
Seelos Therapeutics Inc. logo

Seelos Therapeutics, Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Events That Accelerate or Increase a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

ByQuantisnow·Wall Street's wire, on your screen.
SEEL· Seelos Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SEEL (Seelos Therapeutics Inc.) and more on Quantisnow.